Clinical Trials
22
Active:0
Completed:15
Trial Phases
5 Phases
Early Phase 1:1
Phase 1:4
Phase 2:5
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 3
7 (36.8%)Phase 2
5 (26.3%)Phase 1
4 (21.1%)Not Applicable
2 (10.5%)Early Phase 1
1 (5.3%)Maitake for Integrative Cancer Care
Phase 2
Recruiting
- Conditions
- Cancer
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- The Canadian College of Naturopathic Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT06323473
- Locations
- 🇨🇦
The Centre for Health Innovation, Ottawa, Ontario, Canada
🇨🇦Canadian College of Naturopathic Medicine - Integrative Cancer Centre, Toronto, Ontario, Canada
Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome
Phase 2
Recruiting
- Conditions
- PerinatalAnxietyPerinatal Depression
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- The Canadian College of Naturopathic Medicine
- Target Recruit Count
- 100
- Registration Number
- NCT06074250
- Locations
- 🇨🇦
Sunnybrook Health Science Center, Toronto, Ontario, Canada
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer
- First Posted Date
- 2023-05-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- The Canadian College of Naturopathic Medicine
- Target Recruit Count
- 90
- Registration Number
- NCT05849129
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder
Phase 2
Completed
- Conditions
- Generalized Anxiety Disorder
- First Posted Date
- 2022-10-10
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- The Canadian College of Naturopathic Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT05573672
- Locations
- 🇨🇦
Canadian College of Naturopathic Medicine, Toronto, Ontario, Canada
Dietary Supplements for COVID-19
Phase 3
Terminated
- Conditions
- Covid19
- Interventions
- Drug: Vitamin D3 50,000 IUOther: Microcrystalline Cellulose CapsuleDietary Supplement: Vitamin C/ZincOther: Medium Chain Triglyceride OilDietary Supplement: Vitamin K2/D
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- The Canadian College of Naturopathic Medicine
- Target Recruit Count
- 90
- Registration Number
- NCT04780061
- Locations
- 🇨🇦
The Centre for Health Innovation, Ottawa, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found